Pain News and Research

Latest Pain News and Research

Loughborough research reveals most effective way of boosting muscle strength

Engaging in short, explosive leg contractions is the most effective way of strengthening muscles, Loughborough research reveals.

7 Jun 2016

Spider venom helps investigate pain signals experienced by irritable bowel syndrome patients

Spiders have helped researchers from Australia and the US discover a new target for irritable bowel syndrome pain.

7 Jun 2016

Zika virus directly infects brain progenitor cells in newborns to cause neurological problems

The mosquito-borne Zika virus linked to microcephaly and other neurological problems in newborns of affected mothers directly infects the brain progenitor cells destined to become neurons, UT Southwestern Medical Center researchers report in a study published online today in Cell Reports.

6 Jun 2016

Personlized exercise pattern may help reduce neuropathic symptoms of chemotherapy

Researchers at the University of Rochester Wilmot Cancer Institute discovered something simple and inexpensive to reduce neuropathy in hands and feet due to chemotherapy--exercise.

6 Jun 2016

Cobimetinib combined with vemurafenib shows added benefit for melanoma with BRAF V600 mutation

Cobimetinib has been approved since November 2015 in combination with vemurafenib for the treatment of adults with advanced, i.e. metastatic or unresectable, melanoma with a BRAF V600 mutation.

6 Jun 2016

Metformin along with chemotherapy/radiation improves outcomes in head and neck cancer patients

Researchers at the University of Cincinnati College of Medicine have found that adding increasing doses of an approved Type 2 diabetes drug, metformin, to a chemotherapy and radiation treatment regimen in head and neck cancer patients is not well tolerated if escalated too quickly, but allowing slower escalation could be beneficial.

6 Jun 2016

Nivolumab drug shows better response rate in metastatic bladder cancer patients

The immune checkpoint blockade drug nivolumab reduced tumor burden in 24.4 percent of patients with metastatic bladder cancer, regardless of whether their tumors had a biomarker related to the drug's target, according to clinical trial results from The University of Texas MD Anderson Cancer Center.

6 Jun 2016

Neutral atherosclerosis trial highlights effectiveness of optimal medical therapy

Salsalate has no greater effect than placebo on the progression of coronary artery plaque, show the findings of the randomised TINSAL-CVD trial.

3 Jun 2016

Immunotherapy with experimental monoclonal antibody could reduce neuroblastoma tumors

Neuroblastoma tumors shrank, some dramatically, in 80 percent of newly diagnosed, young, high-risk patients enrolled in a Phase II clinical trial that included an experimental monoclonal antibody. The immunotherapy agent was produced on the St. Jude Children's Research Hospital campus where the study is still underway.

3 Jun 2016

Dr Anjali Mahto explains how to prevent risk of mosquito bites

Nobody likes being bitten by mosquitos whether it’s at home or abroad. Consultant Dermatologist & British Skin Foundation spokesperson, Dr Anjali Mahto explains how to deter the summer pests, what to do when bitten and why they are attracted to us in the first place.

2 Jun 2016

Nonprofits partner to raise awareness of scleroderma

If you've ever silently questioned someone wearing mittens on a warm spring day, the answer may be scleroderma. Or wondered why a woman, who otherwise appeared middle-aged, wore a face as wrinkle-free as her teenage daughter. The answer may be scleroderma.

2 Jun 2016

Deployed military soldiers three times more likely to suffer non-combat musculoskeletal injuries

Since September 11, 2001, an estimated 60,000 U.S. military service members have been injured in combat during the Afghanistan and Iraq wars. Nearly 45,000 of all combat injuries are caused by improvised explosive devices, also known as IEDs.

2 Jun 2016

Duke scientists discover new small-molecule drugs to treat chronic pain

A research team at Duke University has discovered a potential new class of small-molecule drugs that simultaneously block two sought-after targets in the treatment of pain.

1 Jun 2016

Ocaliva drug gets FDA approval for primary biliary cholangitis treatment

On Friday, May 27, the U.S. Food and Drug Administration granted accelerated approval for Ocaliva (obeticholic acid) for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as a single therapy in adults unable to tolerate UDCA.

1 Jun 2016

Risk group system may help better predict long-term consequences from whiplash trauma

Possible long-term consequences from a whiplash trauma can be effectively predicted if the injured persons are subdivided into different risk groups shortly after the car accident. This is shown by a Danish study that was presented at the Congress of the European Academy of Neurology in Copenhagen.

1 Jun 2016

Rome IV criteria helps diagnose, treat gastrointestinal conditions in children

A child feels nauseated all the time, but no medical test can find what is wrong. Or a child vomits regularly, but there's no illness or eating disorder to explain it. These, and other stomach and bowel-related problems with no obvious causes, are called functional gastrointestinal disorders.

1 Jun 2016

Pain News and Research

Latest Pain News and Research

Loughborough research reveals most effective way of boosting muscle strength

Spider venom helps investigate pain signals experienced by irritable bowel syndrome patients

Zika virus directly infects brain progenitor cells in newborns to cause neurological problems

Personlized exercise pattern may help reduce neuropathic symptoms of chemotherapy

Cobimetinib combined with vemurafenib shows added benefit for melanoma with BRAF V600 mutation

Metformin along with chemotherapy/radiation improves outcomes in head and neck cancer patients

Nivolumab drug shows better response rate in metastatic bladder cancer patients

Neutral atherosclerosis trial highlights effectiveness of optimal medical therapy

Immunotherapy with experimental monoclonal antibody could reduce neuroblastoma tumors

Dr Anjali Mahto explains how to prevent risk of mosquito bites

Nonprofits partner to raise awareness of scleroderma

Deployed military soldiers three times more likely to suffer non-combat musculoskeletal injuries

Duke scientists discover new small-molecule drugs to treat chronic pain

Ocaliva drug gets FDA approval for primary biliary cholangitis treatment

Risk group system may help better predict long-term consequences from whiplash trauma

Rome IV criteria helps diagnose, treat gastrointestinal conditions in children

Study identifies persistent opioid use in some patients after knee or hip replacement

Additional drug treatment options to prevent migraine may offer hope to sufferers

Chronic pain goes unnoticed in cognitively impaired individuals with dementia

Neurological problems can impair sexuality

Innovation in neuroscience drug discovery - eBook eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Pain News and Research

Latest Pain News and Research

Innovation in neuroscience drug discovery - eBook eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in